Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2005, p. 1443-1444, Vol. 43, No. 3
0095-1137/05/$08.00+0 doi:10.1128/JCM.43.3.1443-1444.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Department of Medical Microbiology, University of Stellenbosch,1 Department of Pediatrics and Child Health, Tygerberg Hospital, Tygerberg,4 MRC-SA, Parow,2 MRC-SA TB Operational and Policy Research Unit, Pretoria, South Africa3
Received 19 September 2004/ Returned for modification 27 October 2004/ Accepted 14 November 2004
Dihydropteroate synthase (DHPS) gene mutations have raised concerns about emerging sulfonamide resistance in Pneumocystis jirovecii. DHPS and dihydrofolate reductase (DHFR) gene products were amplified in clinical specimens from South African patients. One of 53 DHPS genes sequenced contained the double mutation Thr55Ala Pro57Ser. DHFR gene mutations detected were Ala67Val and the new mutations Arg59Gly and C278T.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»